Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emend IV for salvage treatment of chemotherapy-induced vomiting
NCT01405924Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Oct 2011
- Primary completion
- Dec 2013
01
Overview
A Phase 2 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Merck & Co.. Started Oct 2011; status: terminated.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01405924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405924.